Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 714 in active rheumatoid arthritis
NCT00433875Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2002
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of ordesekimab in rheumatoid arthritis (RA), sponsored by Amgen. Started Dec 2002; status: completed.
02
Drugs
ordesekimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00433875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433875.